CV - Thromboembolic disorders

Guidelines (21)

Current Medical Standards of Fitness to Drive (DVLA Guidance)

31 August 2018

Key advice from DVLA on fitness to drive.

Edoxaban for Preventing Stroke and Systemic Embolism in People With Non‑Valvular Atrial Fibrillation (TA355)

23 September 2015

Edoxaban for Treating and for Preventing Deep Vein Thrombosis and Pulmonary Embolism (TA354)

26 August 2015

Apixaban for the Treatment and Secondary Prevention of Deep Vein Thrombosis and/or Pulmonary Embolism (TA341)

8 June 2015

Rivaroxaban for Preventing Adverse Outcomes after Acute Management of Acute Coronary Syndrome (TA335)

25 March 2015

Dabigatran Etexilate for the Treatment and Secondary Prevention of Deep Vein Thrombosis and/or Pulmonary Embolism (TA327)

17 December 2014

Rivaroxaban for Treating Pulmonary Embolism and Preventing Recurrent Venous Thromboembolism (TA287)

26 June 2013

Apixaban for Preventing Stroke and Systemic Embolism in People with Nonvalvular Atrial Fibrillation (TA275)

27 February 2013

Alteplase for Treating Acute Ischaemic Stroke (TA264 [Review of TA122])

26 September 2012

Rivaroxaban for the Treatment of Deep Vein Thrombosis and Prevention of Recurrent Deep Vein Thrombosis and Pulmonary Embolism (TA261)

27 July 2012

Load More
Tables (1)

Table: Novel Oral Anticoagulants for the Prevention of Stroke

13 June 2018

Dosing of NOACs in non-valvular AF.

Drug Sections (13)

CV - Thromboembolic disorders in the News

'No convincing alternative' to aspirin for secondary cardiovascular prevention, meta-analysis suggests

'No convincing alternative' to aspirin for secondary cardiovascular prevention, meta-analysis suggests

By Chloe Harman, 13 May 2020

In a meta-analysis of randomised trials, patients who...

GPs overestimate benefits and harms of treatments, say researchers

GPs overestimate benefits and harms of treatments, say researchers

By Chloe Harman, 4 March 2020

GPs’ knowledge of the absolute benefits and harms of...

MHRA advises on anticoagulant dose adjustment in patients with renal impairment

MHRA advises on anticoagulant dose adjustment in patients with renal impairment

By Chloe Harman, 30 October 2019

Estimated glomerular filtration rate (eGFR) should...

MIMS Clinics

Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.